Drug-susceptibility patterns of Mycobacterium tuberculosis in Mpumalanga province, South Africa: possible guiding design of retreatment regimen.

AIDS Virus Research Laboratory, Department of Microbiology, University of Venda, South Africa.
Journal of Health Population and Nutrition (Impact Factor: 1.12). 02/2010; 28(1):7-13. DOI: 10.3329/jhpn.v28i1.4518
Source: PubMed

ABSTRACT Multidrug-resistant tuberculosis (MDR-TB) has been a cause of concern in both developed and developing countries. The prevalence of drug resistance in Mycobacterium tuberculosis (MTB) isolates (n=692) from Mpumalanga province was assessed. In total, 692 (64%) MTB strains from cases with pulmonary TB were tested for susceptibility against rifampicin, isoniazid, ethambutol, and streptomycin using the MGIT 960 instrument. Two hundred and nine (30.2%) strains were resistant to one or more drugs. Resistance to one drug ranged from 1.4% for ethambutol to 17.7% for rifampicin. The prevalence of MDR-TB ranged from 6.7% for three drugs to 34% for four drugs, with significant predictors being patients' age-groups of 25-54 years (p=0.0012) and >55 years (p=0.007). The result showed a high level (58.4%) of MDR-TB from cases in Mpumalanga province. To achieve a higher cure rate in this province, drug-susceptibility tests must be done for every case.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: ABSTRACT Emergence of multidrug-resistant tuberculosis (MDR-TB) has been a cause of concern in both developed and developing countries. Hence, there is a need for continuous monitoring of drug resistance to anti-tuberculosis drugs in tuberculosis patients. A study was conducted to determine the prevalence anti-TB drug resistance in Mycobacterium tuberculosis isolates obtained from sputum samples of clinically suspected TB patients with no history of previous anti-TB treatment attending a tertiary care hospital from February 2006 to August 2007 in Pune, India. Mycobacterium tuberculosis isolates were subjected to drug susceptibility testing (DST) to four firstline anti-TB drugs namely Isoniazid, Rifampicin, Streptomycin and Ethambutol by Bactec MGIT 960 system being currently used in the Revised National Tuberculosis Control Program (RNTCP). It was found that MDR-TB prevalence in newly diagnosed pulmonary tuberculosis patients in Pune has not increased compared to the earlier data. Adequate data on MDR-TB at national and regional level are not available. Hence, it is essential to conduct nationwide drug resistance surveillance for TB with continuous monitoring of trends to curb the emergence of drug resistance to ensure the success of tuberculosis control programs in the country.
    Int J Pharm Bio Sci. 07/2013; 4(3):579 - 585.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Mycobacterium tuberculosis complex (MTBC) causes tuberculosis (TB) in humans and animals. We investigated the presence of MTBC in cattle milk and its drug resistance using polymerase chain reaction (PCR). Two hundred samples (100 mL each) were obtained from a dairy farm in the Nkonkobe region of South Africa. The samples were processed using the modified Petroff method. DNA was isolated using a Zymo Bacterial DNA kit and amplified using Seeplex(®) MTB Nested ACE assay. The Genotype(®) Mycobacterium tuberculosis-multidrug resistantplus (MTBDRplus) assay was used to perform drug susceptibility and detection of mutations conferring resistance to isoniazid (INH) and rifampicin (RIF). Eleven samples tested positive for MTBC DNA using the Seeplex(®) MTB Nested ACE assay. The Genotype(®) MTBDRplus assay showed that 10/11 samples were resistant to both INH and RIF i.e., multi-drug resistant (MDR). The most and least frequent rpoB mutations detected in RIF resistant samples were H526Y (9/10) and D516V (2/10) respectively. None of the INH resistant samples harbored mutations in the katG gene. However, all of them harbored the T8A mutation in the inhA gene. These results have clinical and epidemiological significance and calls for further studies and necessary actions to delineate the situation.
    International Journal of Environmental Research and Public Health 06/2012; 9(6):2045-56. · 2.00 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Anti-tubercolosi resistenza ai farmaci nel sud-est della Turchia]

Full-text (2 Sources)

Available from
May 16, 2014